BBOTBridgeBio Oncology Therapeutics, Inc.
- Market cap
- $213.26M
- as of 2026-10-23
- Latest close
- $2.66
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-13
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cobo MarcPrincipal Accounting Officer | Oct 21 | Oct 23 | F | 203 | $2.68 | $544 | 13,812 | No | Form 4 |
| Cobo MarcPrincipal Accounting Officer | Oct 1 | Oct 5 | F | 126 | $3.94 | $496 | 14,015 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Oct 1 | Oct 5 | F | 1,047 | $3.94 | $4,125 | 43,529 | No | Form 4 |
| Beltran PedroPresident and CEO | Oct 1 | Oct 5 | F | 1,047 | $3.94 | $4,125 | 43,529 | No | Form 4 |
| Elmelech IdanCOO & Principal Financial Ofcr | Oct 1 | Oct 5 | F | 343 | $3.94 | $1,351 | 14,152 | No | Form 4 |
| Cobo MarcPrincipal Accounting Officer | Sep 10 | Sep 14 | A | 9,038 | $0.00 | $0 | 14,344 | No | Form 4 |
| Cobo MarcPrincipal Accounting Officer | Sep 10 | Sep 14 | F | 203 | $5.52 | $1,121 | 14,141 | No | Form 4 |
| Cobo MarcPrincipal Accounting Officer | Sep 10 | Sep 14 | A · derivative | 43,700 | $5.52 | $241,224 | 43,700 | No | Form 4 |
| Beltran PedroPresident and CEO | Jul 1 | Jul 6 | F | 1,047 | $7.80 | $8,167 | 44,576 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Jul 1 | Jul 6 | F | 1,047 | $7.80 | $8,167 | 44,576 | No | Form 4 |
| Elmelech IdanCOO & Principal Financial Ofcr | Jul 1 | Jul 6 | F | 343 | $7.80 | $2,675 | 14,495 | No | Form 4 |
| Cobo MarcPrincipal Accounting Officer | Jul 1 | Jul 6 | F | 125 | $7.80 | $975 | 5,306 | No | Form 4 |
| Chen Bihua | Jul 1 | Jul 6 | J | 4,528,186 | $0.00 | $0 | not reported | No | Form 4 |
| Chen Bihua | Jul 1 | Jul 6 | J | 2,692,459 | $0.00 | $0 | 4,879,995 | No | Form 4 |
| Chen Bihua | Jul 1 | Jul 6 | J | 1,704,862 | $0.00 | $0 | 5,010,332 | No | Form 4 |
| Chen Bihua | Jul 1 | Jul 6 | J | 130,865 | $0.00 | $0 | 6,083,221 | No | Form 4 |
| Kumar Neil | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Bauer Jake | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Chen Bihua | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Kelleher Raymond J. | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Lebowitz Peter F | Jun 16 | Jun 18 | A · derivative | 7,289 | $7.73 | $56,344 | 7,289 | No | Form 4 |
| Mccormick Frank | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Tipirneni Praveen P. | Jun 16 | Jun 18 | A · derivative | 31,675 | $7.73 | $244,848 | 31,675 | No | Form 4 |
| Beltran PedroPresident and CEO | May 10 | May 12 | A · derivative | 1,103,837 | $7.66 | $8,455,391 | 1,103,837 | No | Form 4 |
| Elmelech IdanCOO & Principal Financial Ofcr | May 10 | May 12 | A · derivative | 758,222 | $7.66 | $5,807,981 | 758,222 | No | Form 4 |
| Mehra Uneek | Apr 1 | May 5 | F | 524 | $9.03 | $4,732 | 22,806 | No | Form 4 |
| Beltran PedroPresident and CEO | Apr 1 | May 5 | F | 1,047 | $9.03 | $9,454 | 45,623 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Apr 1 | May 5 | F | 1,047 | $9.03 | $9,454 | 45,623 | No | Form 4 |
| Lebowitz Peter F | Mar 24 | Mar 26 | A · derivative | 63,350 | $8.72 | $552,412 | 63,350 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Mar 10 | Mar 12 | A | 46,670 | $0.00 | $0 | 46,670 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Mar 10 | Mar 12 | A · derivative | 210,000 | $10.19 | $2,139,900 | 210,000 | No | Form 4 |
| Beltran PedroChief Scientific Officer | Mar 10 | Mar 12 | A | 46,670 | $0.00 | $0 | 46,670 | No | Form 4 |
| Beltran PedroChief Scientific Officer | Mar 10 | Mar 12 | A · derivative | 210,000 | $10.19 | $2,139,900 | 210,000 | No | Form 4 |
| Mehra UneekChief Financial Officer | Mar 10 | Mar 12 | A | 23,330 | $0.00 | $0 | 23,330 | No | Form 4 |
| Mehra UneekChief Financial Officer | Mar 10 | Mar 12 | A · derivative | 105,000 | $10.19 | $1,069,950 | 105,000 | No | Form 4 |
| Wallace Eli M.Chief Executive Officer | Jan 1 | Jan 5 | A · derivative | 1,114,400 | $12.52 | $13,952,288 | 1,114,400 | No | Form 4 |
| Wallace Eli M.Chief Executive Officer | Dec 10, 2025 | Dec 12, 2025 | D · derivative | 1,114,400 | $12.44 | $13,863,136 | 500,000 | No | Form 4 |
| BridgeBio Pharma, Inc. | Oct 10, 2025 | Oct 16, 2025 | J | 784,720 | not reported | not reported | 14,589,846 | No | Form 4 |
| Wallace Eli M.Chief Executive Officer | Oct 2, 2025 | Oct 6, 2025 | A · derivative | 1,614,400 | $12.44 | $20,083,136 | 1,614,400 | No | Form 4 |
| Mehra UneekChief Financial Officer | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 633,570 | $9.59 | $6,075,936 | 633,570 | No | Form 4 |
| Wallace Eli M.Chief Executive Officer | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 499,731 | $9.59 | $4,792,420 | 499,731 | No | Form 4 |
| Ben YongChief Med & Dev Officer | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 357,177 | $9.59 | $3,425,327 | 357,177 | No | Form 4 |
| Beltran PedroChief Scientific Officer | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 357,177 | $9.59 | $3,425,327 | 357,177 | No | Form 4 |
| Bauer Jake | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 138,193 | $9.59 | $1,325,271 | 138,193 | No | Form 4 |
| Mccormick Frank | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 91,076 | $9.59 | $873,419 | 91,076 | No | Form 4 |
| Tipirneni Praveen P. | Aug 26, 2025 | Aug 28, 2025 | A · derivative | 52,269 | $9.59 | $501,260 | 52,269 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | M | 4,172,126 | not reported | not reported | 4,681,126 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | D | 152,940 | $0.00 | $0 | 4,528,186 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 760,496 | $10.72 | $8,152,517 | 2,187,536 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 639,110 | $10.72 | $6,851,259 | 1,542,710 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 5,598,425 | $10.72 | $60,015,116 | 5,667,785 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 1,905,046 | not reported | not reported | 1,905,046 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 1,762,760 | not reported | not reported | 3,305,470 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | A | 284,571 | not reported | not reported | 5,952,356 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | D · derivative | 307,874 | $0.00 | $0 | 4,172,126 | No | Form 4 |
| Chen Bihua | Aug 11, 2025 | Aug 13, 2025 | M · derivative | 4,172,126 | not reported | not reported | not reported | No | Form 4 |
| Schmid John P. | Aug 11, 2025 | Aug 11, 2025 | M | 30,000 | not reported | not reported | 30,000 | No | Form 4 |
| Schmid John P. | Aug 11, 2025 | Aug 11, 2025 | M · derivative | 30,000 | $0.00 | $0 | not reported | No | Form 4 |
| McKenna Mark C. | Aug 11, 2025 | Aug 11, 2025 | M | 30,000 | not reported | not reported | 30,000 | No | Form 4 |
| McKenna Mark C. | Aug 11, 2025 | Aug 11, 2025 | M · derivative | 30,000 | $0.00 | $0 | not reported | No | Form 4 |
| Holman Albert A III | Aug 11, 2025 | Aug 11, 2025 | M | 30,000 | not reported | not reported | 30,000 | No | Form 4 |
| Holman Albert A III | Aug 11, 2025 | Aug 11, 2025 | M · derivative | 30,000 | $0.00 | $0 | not reported | No | Form 4 |
| Chen BihuaCEO and Chairperson | Feb 8, 2025 | Feb 10, 2025 | J · derivative | 30,000 | $0.00 | $0 | 4,480,000 | No | Form 4 |
| Helix Holdings II LLC | Feb 8, 2025 | Feb 10, 2025 | J · derivative | 30,000 | $0.00 | $0 | 4,480,000 | No | Form 4 |
| Helix Holdings II LLC | Feb 13, 2024 | Feb 13, 2024 | A | 509,000 | $10.00 | $5,090,000 | 509,000 | No | Form 4 |
| Chen BihuaCEO and Chairperson | Feb 13, 2024 | Feb 13, 2024 | A | 509,000 | $10.00 | $5,090,000 | 509,000 | No | Form 4 |
| Chen BihuaCEO and Chairperson | Feb 13, 2024 | Feb 13, 2024 | P | 69,360 | $10.00 | Purchase +$693,600 | 69,360 | No | Form 4 |
| Chen BihuaCEO and Chairperson | Feb 13, 2024 | Feb 13, 2024 | P | 1,427,040 | $10.00 | Purchase +$14,270,400 | 1,427,040 | No | Form 4 |
| Chen BihuaCEO and Chairperson | Feb 13, 2024 | Feb 13, 2024 | P | 903,600 | $10.00 | Purchase +$9,036,000 | 903,600 | No | Form 4 |